Financial information

The information source is the annual report of the company with business id 556238-4361

* Closing information (×1000) SEK

Fiscal year 202412 202312 (consolidated)
Number of months: 12 12
Turnover: 3,484 Revenue Down 7,633 Revenue Up
Financial expenses: 783 Revenue Down 913 Revenue Down
Earnings before taxes: -123,317 Revenue Down -89,322 Revenue Down
Total assets: 172,591 Revenue Down 287,912 Revenue Up
Current assets: 66,645 Revenue Down 179,237 Revenue Up
Current liabilities: 48,467 Revenue Down 58,724 Revenue Up
Equity capital: 115,516 Revenue Down 217,924 Revenue Up
Share capital: 57,309 Revenue Up 52,685 Revenue Up
Number of employees: 10 10 Revenue Up

Financial ratios

Solvency: 66.9% Revenue Down 75.7% Revenue Down
Turnover per employee: 348 Revenue Down 763 Revenue Up
Profitability: -3.539.5% Revenue Down -1.170.2% Revenue Up
Return on equity (ROE): -106.8% Revenue Down -41.0% Revenue Up
Current ratio: 137.5% Revenue Down 305.2% Revenue Down
Return on assets (ROA): -71.0% Revenue Down -30.7% Revenue Up

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202412
Number of months: 12
Turnover: 3,484
Financial expenses: 783
Earnings before taxes: -123,317
Total assets: 172,591
Current assets: 66,645
Current liabilities: 48,467
Equity capital: 115,516
Share capital: 57,309
Number of employees: 10

Financial ratios

Solvency: 66.9%
Turnover per employee: 348
Profitability: -3.539.5%
Return on equity (ROE): -106.8%
Current ratio: 137.5%
Return on assets (ROA): -71.0%